BE1001668A5 - Derives de tetrahydronaphtalene. - Google Patents

Derives de tetrahydronaphtalene. Download PDF

Info

Publication number
BE1001668A5
BE1001668A5 BE8700505A BE8700505A BE1001668A5 BE 1001668 A5 BE1001668 A5 BE 1001668A5 BE 8700505 A BE8700505 A BE 8700505A BE 8700505 A BE8700505 A BE 8700505A BE 1001668 A5 BE1001668 A5 BE 1001668A5
Authority
BE
Belgium
Prior art keywords
sep
compounds
formula
general formula
desc
Prior art date
Application number
BE8700505A
Other languages
English (en)
French (fr)
Inventor
Michael Klaus
Peter Loeliger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH1938/86A external-priority patent/CH668962A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of BE1001668A5 publication Critical patent/BE1001668A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
BE8700505A 1986-05-13 1987-05-11 Derives de tetrahydronaphtalene. BE1001668A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1938/86A CH668962A5 (de) 1986-05-13 1986-05-13 Tetrahydronaphthyl-propenyl-phenole.
CH74287 1987-02-26

Publications (1)

Publication Number Publication Date
BE1001668A5 true BE1001668A5 (fr) 1990-02-06

Family

ID=25685550

Family Applications (1)

Application Number Title Priority Date Filing Date
BE8700505A BE1001668A5 (fr) 1986-05-13 1987-05-11 Derives de tetrahydronaphtalene.

Country Status (20)

Country Link
CN (1) CN87103524A (fi)
AU (1) AU7277987A (fi)
BE (1) BE1001668A5 (fi)
DE (1) DE3715809A1 (fi)
DK (1) DK232087A (fi)
ES (1) ES2005572A6 (fi)
FI (1) FI872027A (fi)
FR (1) FR2598706B1 (fi)
GB (1) GB2190378B (fi)
HU (1) HU198002B (fi)
IL (1) IL82448A0 (fi)
IT (1) IT1203954B (fi)
LU (1) LU86866A1 (fi)
MC (1) MC1817A1 (fi)
NL (1) NL8701101A (fi)
NO (1) NO871961L (fi)
NZ (1) NZ220215A (fi)
PT (1) PT84860B (fi)
SE (1) SE8701933L (fi)
ZW (1) ZW6587A1 (fi)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602130A (en) * 1987-03-20 1997-02-11 Allergan Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
US5264578A (en) 1987-03-20 1993-11-23 Allergan, Inc. Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
CA2017956A1 (en) * 1989-07-06 1991-01-06 Werner Bollag Use of retinoids
US5183827A (en) * 1989-09-19 1993-02-02 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5272156A (en) * 1989-09-19 1993-12-21 Allergan, Inc. Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
US5264456A (en) * 1989-12-29 1993-11-23 Allergan, Inc. Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity
US5324840A (en) * 1992-06-11 1994-06-28 Allergan, Inc. Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
US5455265A (en) * 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
US6172115B1 (en) 1993-02-11 2001-01-09 Allergan Sales, Inc. Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid
US5475022A (en) * 1993-10-18 1995-12-12 Allergan, Inc. Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity
US5426118A (en) * 1993-12-30 1995-06-20 Allergan, Inc. [4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity
US5498755A (en) * 1994-08-23 1996-03-12 Chandraratna; Roshantha A. Disubstituted aryl and heteroaryl imines having retinoid-like biological activity
US5618943A (en) * 1994-12-29 1997-04-08 Allergan Acetylenes disubstituted with a 5 OXO substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5514825A (en) * 1994-12-29 1996-05-07 Allergan, Inc. Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5534641A (en) * 1994-12-29 1996-07-09 Allergan Acetylenes disubstituted with 2-tetrahydropyranoxyaryl and aryl or heteroaryl groups having retinoid-like biological activity
US5556996A (en) * 1994-12-29 1996-09-17 Allergan Oxiranyls disubstituted with a phenyl group and a substituted chromanyl or tetrahydroquinolinyl group having retinoid like activity
US5648514A (en) 1994-12-29 1997-07-15 Allergan Substituted acetylenes having retinoid-like biological activity
US5489584A (en) * 1994-12-29 1996-02-06 Allergan, Inc. Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5543534A (en) * 1994-12-29 1996-08-06 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl or heteroaryl groups having retinoid-like biological activity
US5618931A (en) * 1994-12-29 1997-04-08 Allergan Acetylenes disubstituted with a 5 substituted dihydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
US5599967A (en) * 1994-12-29 1997-02-04 Allergan Acetylenes disubstituted with a 5 substituted tetrahydronaphthyl group and with an aryl of heteroaryl group having retinoid-like biological activity
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
US6025388A (en) 1995-04-26 2000-02-15 Allergan Sales, Inc. Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids
US5616712A (en) * 1995-05-16 1997-04-01 Allergan Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-thio-1,2,3,4-tetrahdroquinolinyl, 2-alkylthio-3,4-dihydroquinolinyl or 2-alkoxy-3,4-dihydroquinolinyl group having retinoid-like biological activity
US5917082A (en) 1995-06-06 1999-06-29 Allergan Sales, Inc. 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5675033A (en) * 1995-06-06 1997-10-07 Allergan 2,4-pentadienoic acid derivatives having retinoid-like biological activity
US5952345A (en) 1995-09-01 1999-09-14 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US6008204A (en) 1995-09-01 1999-12-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US5958954A (en) 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
US6218128B1 (en) 1997-09-12 2001-04-17 Allergan Sales, Inc. Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities
AU7598596A (en) * 1995-11-01 1997-05-22 Allergan, Inc. Sulfides, sulfoxides and sulfones disubstituted with a tetrahydronaphthalenyl, chromanyl, thiochromanyl or tetrahydroquinolinyl and substituted phenyl or heteroaryl group, having retinoid-like biological activity
US5663357A (en) 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
US5675024A (en) 1995-11-22 1997-10-07 Allergan Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4,-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
US5965606A (en) 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US5688957A (en) * 1995-12-29 1997-11-18 Allergan (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
US5723666A (en) * 1996-06-21 1998-03-03 Allergan Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5808124A (en) * 1996-06-21 1998-09-15 Allergan O- or S-substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US6555690B2 (en) 1996-06-21 2003-04-29 Allergan, Inc. Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5747542A (en) * 1996-06-21 1998-05-05 Allergan Oxo-substituted tetrahydronaphthalene derivatives having retinold and/or retinoid antagonist-like biological activity
US5741896A (en) 1996-06-21 1998-04-21 Allergan O- or S- substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5773594A (en) 1996-06-21 1998-06-30 Allergan Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
US5763635A (en) * 1996-06-21 1998-06-09 Allergan Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity
US5739338A (en) * 1996-11-05 1998-04-14 Allergan N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity
US5728846A (en) 1996-12-12 1998-03-17 Allergan Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives
US5760276A (en) 1997-03-06 1998-06-02 Allergan Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
US6037488A (en) 1997-04-19 2000-03-14 Allergan Sales, Inc. Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity
US5919970A (en) 1997-04-24 1999-07-06 Allergan Sales, Inc. Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity
US6380256B1 (en) 2000-08-29 2002-04-30 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6369225B1 (en) 2000-08-29 2002-04-09 Allergan Sales, Inc. Compounds having activity as inhibitors of cytochrome P450RAI
US6313107B1 (en) 2000-08-29 2001-11-06 Allergan Sales, Inc. Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
EP0058370A1 (de) * 1981-02-13 1982-08-25 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Tetrahydronaphthalin- und Indanverbindungen, ihre Herstellung und pharmazeutische Präparate
EP0084667A2 (de) * 1982-01-23 1983-08-03 BASF Aktiengesellschaft Phenylethylen-Derivate, ihre Herstellung und Verwendung als Arzneimittel
EP0232779A1 (de) * 1986-01-28 1987-08-19 BASF Aktiengesellschaft Vinylphenolderivate, ihre Herstellung und Verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3202100A1 (de) * 1982-01-23 1983-08-04 Basf Ag, 6700 Ludwigshafen Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
EP0058370A1 (de) * 1981-02-13 1982-08-25 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Tetrahydronaphthalin- und Indanverbindungen, ihre Herstellung und pharmazeutische Präparate
EP0084667A2 (de) * 1982-01-23 1983-08-03 BASF Aktiengesellschaft Phenylethylen-Derivate, ihre Herstellung und Verwendung als Arzneimittel
EP0232779A1 (de) * 1986-01-28 1987-08-19 BASF Aktiengesellschaft Vinylphenolderivate, ihre Herstellung und Verwendung

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF CHROMATOGRAPHY, vol. 419, 1987, pages 253-262, Elsevier Science Publishers B.V., Amsterdam, NL; C.V. PUGLISI et al.: "Determination of (E)-1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-(1-methyl-2-phenylethenyl)naphthalene, an antiacne agent, and its phenolic metabolite in plasma by reversed-phase high-performance liquid chromatography" *

Also Published As

Publication number Publication date
DK232087D0 (da) 1987-05-06
NL8701101A (nl) 1987-12-01
MC1817A1 (fr) 1988-03-18
ZW6587A1 (en) 1987-12-02
PT84860B (pt) 1990-02-08
GB2190378B (en) 1990-11-14
GB2190378A (en) 1987-11-18
NO871961D0 (no) 1987-05-12
PT84860A (en) 1987-06-01
FR2598706A1 (fr) 1987-11-20
AU7277987A (en) 1987-11-19
FI872027A0 (fi) 1987-05-07
IT8720232A0 (it) 1987-04-23
DE3715809A1 (de) 1987-11-19
HU198002B (en) 1989-07-28
GB8711205D0 (en) 1987-06-17
SE8701933L (sv) 1987-11-14
DK232087A (da) 1987-11-14
HUT43806A (en) 1987-12-28
LU86866A1 (de) 1988-06-13
SE8701933D0 (sv) 1987-05-11
ES2005572A6 (es) 1989-03-16
NO871961L (no) 1987-11-16
NZ220215A (en) 1990-06-26
FR2598706B1 (fr) 1990-07-06
IL82448A0 (en) 1987-11-30
CN87103524A (zh) 1987-12-02
FI872027A (fi) 1987-11-14
IT1203954B (it) 1989-02-23

Similar Documents

Publication Publication Date Title
BE1001668A5 (fr) Derives de tetrahydronaphtalene.
BE1000660A5 (fr) Derives de tetrahydronaphtalene et d'indane.
US4539154A (en) Polyene compounds
CZ703288A3 (en) Benzocycloheptene derivatives and their use as a medicament
US4309407A (en) Alkenyl-substituted thienylalkanecarboxylic acids and derivatives thereof
EP0059983B1 (en) Substituted biphenyl compounds for use as a medicament
US4686235A (en) Substituted cinnamyl-2,3-dihydrobenzofuran and analogs useful as anti-inflammatory agents
JPH0449533B2 (fi)
JP4384495B2 (ja) 固体のベンズアゼピン化合物の塩および医薬化合物の調製におけるそれらの使用
JPH0379336B2 (fi)
US4778818A (en) Substituted 2-(heteroaryl-2-propenyl)phenols useful as anti-inflammatory agents
EP0337885B1 (fr) Nouveaux dérivés triéniques de structure chroménique, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
US4067998A (en) 2-((3,5-Di-tert-butylphenyl)thio) alkanoic acids and derivatives
BE897118A (fr) Composes polyethyleniques
US4405810A (en) 7-Aryl-hept-5-ynoic acids and derivatives thereof
LU83273A1 (fr) Thiazoles
FR2556592A1 (fr) Compositions pharmaceutiques contenant des derives de l'acide campho-methylidene cinnamique
JPS6248639A (ja) 薬剤化合物
BE621255A (fi)
JPS62267245A (ja) テトラヒドロナフタレン誘導体
EP0067008B1 (en) Esters of the carboxylic acid
US5371284A (en) Phenyl acetylenic acetals
KR820000543B1 (ko) 폴리엔 화합물의 제조방법
JPS6092230A (ja) １−（３，４−ジヒドロキシフエニル）アルカン
FR2514347A1 (fr) Acide 2-(para- (2 substitue ou non substitue-3,3,3- trifluoropropyl) phenyl) propionique ou l'un de ses sels et leur utilisation comme medicament

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE A.G.

Effective date: 19910531